X0609 4 2026-10-02 0001652130 Intellia Therapeutics, Inc. NTLA 0002019493 Dube Michael P false C/O INTELLIA THERAPEUTICS, INC. 400 TECHNOLOGY SQUARE, SUITE 100 CAMBRIDGE MA 02139 false true false false VP, Chief Accounting Officer false Common Stock 2026-10-02 4 S false 1864 12.43 D 65022 D Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person. James Basta, attorney-in-fact 2026-10-06